Laura Serwer

Laura Serwer

Company: CRISPR Therapeutics

Job title: Senior Director, Head of Pharmacology and Toxicology


Dr. Serwer leads the in vivo pharmacology and toxicology teams at CRISPR Therapeutics, and her team has lead nonclinical safety efforts for multiple INDs/CTAs for CRISPR-based therapeutics across oncology and metabolic indications. Prior to working at CRISPR Therapeutics, Dr. Serwer led toxicology programs for several IND-stage large molecule therapeutics.


Panel Discussion: Ensuring Product Safety When Moving Into the Clinic 10:00 am

Outlining a checklist of necessary steps for comprehensively demonstrating product safety Practical steps for validating the specificity of a CRISPR/Cas therapy Safety experiments, analysis, and presentation to regulators to transition into the clinic Key considerations for product safety profiling with different delivery approachesRead more

day: Day 1 AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.